UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

The New England journal of medicine, 2005-12, Vol.353 (23), p.2450-2461

2005

Volltextzugriff (PDF)

Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

Nucleosides, nucleotides & nucleic acids, 2004-12, Vol.23 (8-9), p.1111-1116

2004

Volltextzugriff (PDF)

Magnetic resonance imaging in the quantitative assessment of gouty tophi

International journal of clinical practice (Esher), 2006-04, Vol.60 (4), p.408-414

2006

Volltextzugriff (PDF)

Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness

International journal of clinical practice (Esher), 2006-10, Vol.60 (10), p.1210-1217

2006

Volltextzugriff (PDF)

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population

Journal of rheumatology, 2004-08, Vol.31 (8), p.1582

2004

Volltextzugriff (PDF)

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial

Arthritis and rheumatism, 2008-11, Vol.59 (11), p.1540-1548

2008

Volltextzugriff (PDF)

Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims

Journal of rheumatology, 2004-08, Vol.31 (8), p.1575

2004

Volltextzugriff (PDF)

The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase

Journal of clinical pharmacology, 2006-01, Vol.46 (1), p.88-102

2006

Volltextzugriff (PDF)

Outcome measures for acute and chronic gout

Journal of rheumatology, 2005-12, Vol.32 (12), p.2452

2005

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment

American journal of therapeutics, 2005-01, Vol.12 (1), p.22-34

2005

Volltextzugriff (PDF)

Tophaceous gout: quantitative evaluation by direct physical measurement

Journal of rheumatology, 2005-12, Vol.32 (12), p.2368

2005

Volltextzugriff (PDF)

Prevalence of Comorbid Conditions and Prescription Medication Use Among Patients With Gout and Hyperuricemia in a Managed Care Setting

Journal of clinical rheumatology, 2004-12, Vol.10 (6), p.308-314

2004

Volltextzugriff (PDF)

PI-55

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P21-P21

2006

Volltextzugriff (PDF)

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout

Arthritis and rheumatism, 2005-03, Vol.52 (3), p.916-923

2005

Volltextzugriff (PDF)

Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

ChemInform, 2005-03, Vol.36 (9), p.no-no

2005

Volltextzugriff (PDF)

REDUCTION IN GOUT FLARES AND TOPHUS SIZE IN THE 52-WEEK FEBUXOSTAT ALLOPURINOL CONTROLLED TRIAL (FACT): 28

Journal of clinical rheumatology, 2006-08, Vol.12 (Supplement), p.S9

2006

Volltextzugriff (PDF)

Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness: GOUT ASSESSMENT QUESTIONNAIRE

International journal of clinical practice (Esher), 2006-10, Vol.60 (10), p.1210-1217

2006

Volltextzugriff (PDF)

ORIGINAL PAPER: Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness

International journal of clinical practice (Esher), 2006-10, Vol.60 (10), p.1210

2006

Volltextzugriff (PDF)

ORIGINAL PAPER: Magnetic resonance imaging in the quantitative assessment of gouty tophi

International journal of clinical practice (Esher), 2006-04, Vol.60 (4), p.408

2006

Volltextzugriff (PDF)

Magnetic resonance imaging in the quantitative assessment of gouty tophi: Magnetic Resonance Imaging of Tophi

International journal of clinical practice (Esher), 2006-04, Vol.60 (4), p.408-414

2006

Volltextzugriff (PDF)

Effect of food or antacid on febuxostat pharmacokinetics and pharmacodynamics in healthy subjects

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P50-P50

2005

Volltextzugriff (PDF)

Effects of age and gender on febuxostat pharmacokinetics, pharmacodynamics, and safety in healthy subjects

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P50-P50

2005

Volltextzugriff (PDF)

Effect of febuxostat on pharmacokinetics of desipramine, a CYP2D6 substrate, in healthy subjects

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P43-P43

2005

Volltextzugriff (PDF)

Outcome evaluations in gout

Journal of rheumatology, 2007-06, Vol.34 (6), p.1381

2007

Volltextzugriff (PDF)

Errata

The Consultant pharmacist, 2006-01, Vol.21 (1), p.76-77

2006

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Female
(11)
Male
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Middle Aged
(10)
Adult
(9)
Metabolic Diseases
(9)
Other Metabolic Disorders
(9)
Purines And Pyrimidines
(9)
Diseases Of The Osteoarticular System
(7)
Gout
(7)
Rheumatology
(7)
Febuxostat
(6)
Aged
(5)
Uric Acid - Blood
(5)
Xanthine Oxidase - Antagonists & Inhibitors
(5)
Gout - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

6 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

Magnetic resonance imaging in the quantitative assessment of gouty tophi

Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial

Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims

The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase

Outcome measures for acute and chronic gout

Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment

Tophaceous gout: quantitative evaluation by direct physical measurement

Prevalence of Comorbid Conditions and Prescription Medication Use Among Patients With Gout and Hyperuricemia in a Managed Care Setting

PI-55

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout

Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

REDUCTION IN GOUT FLARES AND TOPHUS SIZE IN THE 52-WEEK FEBUXOSTAT ALLOPURINOL CONTROLLED TRIAL (FACT): 28

Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness: GOUT ASSESSMENT QUESTIONNAIRE

ORIGINAL PAPER: Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness

ORIGINAL PAPER: Magnetic resonance imaging in the quantitative assessment of gouty tophi

Magnetic resonance imaging in the quantitative assessment of gouty tophi: Magnetic Resonance Imaging of Tophi

Effect of food or antacid on febuxostat pharmacokinetics and pharmacodynamics in healthy subjects

Effects of age and gender on febuxostat pharmacokinetics, pharmacodynamics, and safety in healthy subjects

Effect of febuxostat on pharmacokinetics of desipramine, a CYP2D6 substrate, in healthy subjects

Outcome evaluations in gout

Errata

Suchergebnisse filtern